| 000 | 01584 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517022853.0 | ||
| 264 | 0 | _c20160125 | |
| 008 | 201601s 0 0 eng d | ||
| 022 | _a1744-6880 | ||
| 024 | 7 |
_a10.1097/FPC.0000000000000136 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBatalla, Ana | |
| 245 | 0 | 0 |
_aThe Cw6 and late-cornified envelope genotype plays a significant role in anti-tumor necrosis factor response among psoriatic patients. _h[electronic resource] |
| 260 |
_bPharmacogenetics and genomics _cJun 2015 |
||
| 300 |
_a313-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadministration & dosage |
| 650 | 0 | 4 |
_aCornified Envelope Proline-Rich Proteins _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHLA-C Antigens _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
| 650 | 0 | 4 | _aSequence Deletion |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aCoto, Eliecer | |
| 700 | 1 | _aGonzález-Fernández, Daniel | |
| 700 | 1 | _aGonzález-Lara, Leire | |
| 700 | 1 | _aGómez, Juan | |
| 700 | 1 | _aSantos-Juanes, Jorge | |
| 700 | 1 | _aQueiro, Rubén | |
| 700 | 1 | _aCoto-Segura, Pablo | |
| 773 | 0 |
_tPharmacogenetics and genomics _gvol. 25 _gno. 6 _gp. 313-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/FPC.0000000000000136 _zAvailable from publisher's website |
| 999 |
_c24727884 _d24727884 |
||